Chronic alcohol use disorder often leads to a hidden state of severe energy depletion in the body, where thiamine (vitamin B1) plays a pivotal role in maintaining efficient energy production in the brain. Alcohol not only accelerates its consumption but also hinders absorption and depletes reserves, triggering a gradual crisis in the nervous system that can culminate in serious, permanent conditions like Wernicke-Korsakoff syndrome.
By Bernd Guzek, MD, PhD
The Biochemical Role — Why Individuals with Alcohol Use Disorder Require Elevated Levels of Vitamin B1
Vitamin B1, or thiamine, acts like a catalyst in energy metabolism, much like a spark plug ignites fuel in an engine. Without adequate thiamine, the system’s efficiency plummets. This issue is particularly acute for those with heavy alcohol consumption, as it disrupts normal metabolic processes.
Alcohol imposes an unnatural burden on metabolism by requiring the body to handle substantial quantities of ethanol alongside carbohydrates. Thiamine is essential for activating enzymes that convert glucose into usable cellular energy. A deficiency results in accumulations of pyruvate and lactate, impairing mitochondrial function—the cell’s energy hubs—and precipitating a metabolic emergency in the brain.
The problem compounds because alcohol not only heightens thiamine demand but also sabotages its uptake, storage, and conversion. Intestinal transport efficiency drops, liver reserves diminish in cases of fatty liver or cirrhosis, and the transformation to active thiamine pyrophosphate is compromised. Compounded by dietary deficiencies, this leads to a vicious cycle.
This confluence creates a biochemical storm: surging needs meet plummeting supplies, with already limited reserves. The brain suffers most due to its reliance on constant energy. Thiamine shortage here fosters dysfunction, inflammation, and lasting harm, explaining why conditions like Wernicke’s encephalopathy, Korsakoff syndrome, and alcoholic neuropathies are prevalent.
Essentially, alcohol targets the very vitamin critical for sustaining energy pathways. For many with alcohol use disorder, thiamine deficiency isn’t occasional—it’s chronic.
Why Thiamine Deficiency Prevails in Alcohol Use Disorder
Multiple interconnected factors exacerbate the issue, often compounding each other.
Nutritional shortfalls: Individuals with alcohol use disorder frequently have imbalanced diets, deriving calories primarily from alcohol, with irregular meals lacking thiamine-rich foods.
Impaired intestinal uptake: Alcohol disrupts thiamine absorption in the gut and damages mucosal linings, reducing intake further.
Reduced hepatic storage: Even healthy livers hold limited thiamine; alcohol-induced damage like fatty liver disease depletes these faster, while hindering activation to its functional form.
Elevated metabolic needs: Ongoing stress from alcohol, inflammation, and post-binge refeeding spikes demand. Coexisting magnesium deficiency—common in this population—further blocks B1 utilization.
This synergy results in a body perpetually short on thiamine while expending it excessively. Consequently, deficiency becomes standard in alcohol use disorder.
Consequences: Neurological Disorders and Peripheral Damage
Acute thiamine scarcity rapidly affects the central and peripheral nervous systems.
Wernicke’s encephalopathy typically develops subtly. Only about 20% exhibit the full triad of oculomotor issues, gait instability, and mental confusion. Many present with vague restlessness or disorientation. Untreated, it progresses to Korsakoff syndrome in up to 80% of cases.
Korsakoff syndrome involves profound amnesia, fabrications, and disrupted personal memory recall. Recovery is partial at best, often necessitating ongoing support.
Peripheral neuropathies from thiamine lack include sensory disturbances like numbness or pain in extremities. Rarely, it manifests as “wet beriberi” with cardiac failure; more commonly in Western contexts, it contributes to cardiomyopathy alongside alcohol’s direct toxicity.
Vitamin B1’s Critical Function During Alcohol Withdrawal
In withdrawal, glucose metabolism resumes abruptly. Administering glucose without thiamine exacerbates cerebral energy deficits. Hence the protocol: thiamine precedes glucose administration.
Guidelines from bodies like the Royal College of Physicians (2002, updated), ASAM (American Society of Addiction Medicine), and German S3 (valid through 2025) mandate thiamine for all withdrawing patients. For suspected Wernicke’s, intravenous doses of 250–500 mg two to three times daily for 3–5 days are standard; lower amounts are insufficient per recent reviews.
Thiamine in withdrawal isn’t merely supportive—it’s a vital prophylactic against irreversible neurological harm.
The Ongoing Need for Vitamin B1 Post-Withdrawal
Post-detox, depleted reserves and absorption issues linger. While improved nutrition helps, full recovery of gut and liver function takes months.
Sustained thiamine can mitigate neuropathies and enhance cognition. Its safety allows extended use, as endorsed in recent 2023 reviews like Habas et al.
Choosing Between Standard Thiamine and Benfotiamine
For emergencies like withdrawal or Wernicke’s risk, intravenous thiamine hydrochloride is mandatory for rapid brain penetration. Oral benfotiamine acts too slowly here.
In maintenance, benfotiamine excels with superior bioavailability—achieving 5 times higher blood levels—and better tissue saturation, per 2023 studies like Bozic and Lavrnja. Clinical trials (e.g., Woelk 1998) confirm its efficacy over thiamine for alcoholic neuropathy, reducing symptoms like pain and numbness more effectively.
- Acute phase (withdrawal, Wernicke risk): High-dose thiamine IV or IM (300–1000 mg/day for 3–5 days). Oral benfotiamine is too slow.
- Long-term therapy & prevention: Benfotiamine 300–600 mg daily is the current gold standard for chronic alcohol use disorder and alcohol-related polyneuropathy.
- Why: Benfotiamine achieves significantly higher tissue levels and has demonstrated superior efficacy compared to standard thiamine in clinical studies.
Practical Recommendation
- Acute phase (withdrawal, Wernicke risk): Physicians will administer high-dose thiamine IV or IM for 3–5 days; oral benfotiamine is too slow in this situation.
- Long-term therapy & prevention: Benfotiamine 300–600 mg per day is widely regarded as the gold standard in chronic alcohol use disorder, especially when polyneuropathy is already present.
In acute settings, only parenteral thiamine reliably reaches the central nervous system fast enough. For ongoing treatment and supplementation, benfotiamine is the better choice.
Should Every Person Still Drinking Take Vitamin B1?
A blanket recommendation is tricky, but the facts are compelling: thiamine deficiency is extremely common, the risks are enormous, and the safety profile is outstanding. Many addiction specialists therefore recommend prophylactic thiamine (often as benfotiamine) for heavy drinkers, especially when nutrition is poor.
However, it must be crystal clear: Vitamin B1 does NOT prevent cirrhosis, pancreatitis, or alcohol-related cancers. It only protects against one specific group of complications caused by thiamine deficiency. In other words: taking a vitamin is not a license to keep drinking. Message received?
During acute withdrawal, thiamine must never be considered self-treatment. High doses and possibly IV administration belong in medical hands only.
Conclusion
For people with alcohol use disorder, vitamin B1 is not a minor vitamin—it is a critical building block for stabilizing energy metabolism, especially in the brain. Alcohol disrupts thiamine supply at multiple levels simultaneously. That’s why Wernicke’s and Korsakoff syndromes are so feared, and why thiamine administration in withdrawal can be literally life-saving.
Long-term benfotiamine supplementation can help cushion nerve damage and stabilize metabolism—but it never replaces the decision to live alcohol-free.
Frequently Asked Questions about thiamin (FAQ)
Why is vitamin B1 so important for people with alcohol use disorder?
Vitamin B1 (thiamine) is essential for energy production in the brain. Alcohol massively increases demand while simultaneously blocking absorption, depleting stores, and impairing activation. This pushes many heavy drinkers into thiamine deficiency, which promotes brain damage and nerve disease.
How do I know if I have a vitamin B1 deficiency?
Symptoms include fatigue, poor concentration, irritability, memory problems, burning/tingling/numbness in hands and feet. In severe cases: unsteady gait, confusion, eye movement problems—then it’s a medical emergency (possible Wernicke’s encephalopathy).
What role does vitamin B1 play in acute alcohol withdrawal?
During withdrawal the brain suddenly needs glucose again. Without enough thiamine, giving glucose can precipitate or worsen Wernicke’s encephalopathy. Guidelines therefore require high-dose parenteral thiamine (often 250–500 mg IV 2–3 times daily) before any glucose.
What’s the difference between thiamine and benfotiamine?
Thiamine is the standard water-soluble form—essential IV in acute situations because it rapidly reaches the brain. Benfotiamine is a fat-soluble pro-drug with far better oral absorption and much higher tissue levels, especially in nerves, and has proven more effective for polyneuropathy.
What dose of benfotiamine is recommended for alcohol-related polyneuropathy?
Clinical studies and European guidelines typically use 300–600 mg benfotiamine daily. This dosage has proven effective and safe for alcohol-related polyneuropathy and long-term prevention.
Can I just take vitamin B1 while I’m still drinking?
Many addiction specialists recommend prophylactic thiamine/benfotiamine for heavy drinkers with poor nutrition. However: it only protects against thiamine-deficiency complications—it does NOT prevent cirrhosis, pancreatitis, or cancer and is never an excuse to continue drinking.
How long should I take vitamin B1 after quitting alcohol?
Duration depends on prior damage and nutritional status. Benfotiamine is often continued for many months (sometimes years) to stabilize nerve function and cognition. Always discuss with your physician.
Selected Studies & References
References (Selection)
- Thomson AD et al. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke’s encephalopathy… Alcohol Alcohol. 2002.
- Habas E et al. Wernicke encephalopathy: an updated narrative review. Saudi J Med Med Sci. 2023.
- DGPPN, DG-SUCHT. German S3-Guideline “Screening, Diagnosis and Treatment of Alcohol-Related Disorders”. AWMF 076-001, valid until 2025.
- Woelk H et al. Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I). Alcohol Alcohol. 1998.
- Bozic I, Lavrnja I. Thiamine and benfotiamine: focus on their therapeutic potential. Heliyon. 2023.
Latest posts on our blog
- The Hidden Energy Theft: How Alcohol Secretly Drains Your Brain’s Most Vital Vitamin
- Bill Wilson, Founder of Alcoholics Anonymous, and His Vitamin Therapy for Alcoholism
- Alcoholic Cardiomyopathy – When Alcohol Attacks the Heart Muscle
- Could Vitamin D Be the Key to Beating Addiction?
- Alcohol is no vitamin source – and never healthy
- Psychiatric effects of nutritional deficiencies in alcoholism
- Alcohol to blame for more than 700,000 cancers annually
- England: Alcohol kills 20 percent more people during Corona
- Vitamin B1 against heart damage caused by alcohol
- Female lawyers drink more often than their male colleagues

Bernd Guzek, MD, PhD
Physician, author, family member of person in recovery from alcohol use disorder & co-founder of Bye, Bye, Booze
Has worked for many years on the biochemistry of addiction and brain metabolism disorders and on how nutrients can influence them.
